European strategies for early intervention in stroke. A report of an Ad Hoc Consensus Group meeting

Cerebrovascular Diseases

Volumn 6, Issue 5, 1996, Pages 315-324

  Bogousslavsky, Julien ^a   Brott, Thomas ^b   Diener, Hans Christoph ^c   Fieschi, Cesare ^d   Hacke, Werner ^e,i   Kaste, Markku ^f   Orgogozo, Jean Marc ^g   Wahlgren, Nils Gunnar ^h  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^c UNIVERSITY OF DUISBURG ESSEN   (Germany)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e UNIVERSITY OF HEIDELBERG   (Germany)

^f UNIVERSITY OF HELSINKI   (Finland)

^g UNIVERSITÉ DE BORDEAUX   (France)

^h STOCKHOLM UNIVERSITY   (Sweden)

ⁱ Department of Neurology ^*  (Germany)

Author keywords

Early intervention; Education; Future therapeutic opportunities; Stroke treatment; Stroke units; Thrombolytic therapy

Indexed keywords

ALTEPLASE; FIBRINOLYTIC AGENT; STREPTOKINASE;

BLEEDING; BLOOD ANALYSIS; BLOOD PRESSURE MONITORING; COMPUTER ASSISTED TOMOGRAPHY; DOPPLER ECHOGRAPHY; ELECTROCARDIOGRAPHY; ELECTROCARDIOGRAPHY MONITORING; EMERGENCY MEDICINE; FIBRINOLYTIC THERAPY; HUMAN; INTENSIVE CARE UNIT; OXYGEN SATURATION; PATIENT MONITORING; PRACTICE GUIDELINE; PRIORITY JOURNAL; RESPIRATORY FUNCTION; REVIEW; STROKE; TEMPERATURE MEASUREMENT; TREATMENT OUTCOME;

EID: 0029756614     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000108045     Document Type: Review

References (55)

1. Ischemic Stroke. Cognos Study 25. Waltham/ Mass, Decision Resources Inc, 1995, pp 7-12.
2. Bonita R: Epidemiology of stroke. Lancet 1992;339:342-344.
3. Wade DT, Wood VA, Langton Hewer R: Use of hospital resources by acute stroke patients. J R Coll Physicians Lond 1985;19:48-52.
4. Isard PA, Forbes JF: The cost of stroke to the National Health Service in Scotland. Cerebrovasc Dis 1992;2:47-50.
5. Forbes JF: Cost of stroke. Scott Med J 1993;38(suppl):S1-S4.
6. Asplund K, Marké L-Å Terént A, Gustafsson C, Wester PO: Costs and gains in stroke prevention: European perspective. Cerebrovasc Dis 1993;3(suppl 1):34-42.
7. Bonner LL, Kanter DS, Manson JE: Primary prevention of stroke. N Engl J Med 1995;333: 1392-1400.
8. Marshall RS, Mohr IP: Current management of ischaemic stroke. J Neurol Neurosurg Psychiatry 1993;56:6-16.
9. Adams HP, Brott TG, Crowell RM, Furlan AJ, Gomez CR, Grotta J, Helgason CM, Marler JR, Woolson RF, Zivin JA, Feinberg W, Mayberg M: Guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 1994;25:1901-1914.
10. National Stroke Association. The Stroke/Brain Attack Reporter's Handbook. Englewood, Colo., National Stroke Association, 1995.
11. Alberts MJ, Bertels C, Dawson DV: An analysis of the time of presentation after stroke. JAMA 1990;263:65-68.
12. Alberts NJ, Perry A, Dawson DV, Bertels C: Effects of public and professional education on reducing the delay in presentation and referral of stroke patients. Stroke 1992;23:352-356.
13. Barsan WG, Brott TG, Broderick JP, Haley EC, Levy DE, Marler JR: Time of hospital presentation in patients with acute stroke. Arch Intern Med 1993;153:2558-2561.
14. Barsan WG, Brott TG, Broderick JP, Haley EC Jr, Levy DE, Marler JR: Urgent therapy for acute stroke. Effects of a stroke trial on untreated patients. Stroke 1994;25:2132-2137.
15. Pulsinelli W: Pathophysiology of acute ischaemic stroke. Lancet 1992;339:533-536.
16. A Working Group on Emergency Brain Resuscitation: Emergency brain resuscitation. Ann Intern Med 1995;122:622-627.
17. Hossmann K-A: Viability thresholds and the penumbra of focal ischemia. Ann Neurol 1994;36:557-565.
18. Toni D, Fiorelli M, Gentile M, Bastianello S, Sacchhetti ML, Argentino C, Pozzilli C, Fieschi C: Progressing neurological deficit secondary to acute ischemic stroke: A study on predictability, pathogenesis and prognosis. Arch Neurol 1995;52:670-675.
19. Toni D, Fiorelli M, Bastianello S, et al.: Hemorrhagic transformation of brain infarct: Predictability in the first 5 hours from stroke onset and influence on clinical outcome. Neurology 1996;46:341-345.
20. Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R, Boysen G, Bluhmki E, Höxter G, Mahagne M-H, Hennerici M, ECASS Study Group: Intravenous thrombolysis with tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 1995;274: 1017-1025.
21. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group: Tissue plasminogen activator for acute stroke. N Engl J Med 1995;333:1581-1587.
22. Kothari R, Barsan W, Brott T, Broderick J, Ashbrook S: Frequency and accuracy of pre-hospital diagnosis of stroke. Stroke 1995;26: 937-941.
23. Donnan GA, Davis SM, Chambers BR, Gates PC, Hankey GJ, McNeill JJ, Rosen D, Stewart-Wynne EG, Tuck RG: Trials of streptokinase in severe acute ischaemic stroke. Lancet 1995;345:578-579.
24. Hommel M, Boissel JP, Cornu C, Boutitie F, Lees KR, Besson G, Leys D, Amarenco P, Bogaert M, MAST Study Group: Termination of trial of streptokinase in severe acute ischaemic stroke. Lancet 1994;345:57.
25. Multicentre Acute Stroke Trial-Italy (MAST-I) Group: Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke. Lancet 1995;346:1509-1514.
26. National Stroke Association: Cost of stroke. Stroke Clin Updates 1994;5:9-12.
27. Smurawska LT, Alexandrov AV, Bladin CF, Norris JW: Cost of acute stroke care in Toronto, Canada. Stroke 1994;8:1628-1631.
28. Del Zoppo GJ: Acute stroke: On the threshold of a therapy? N Engl J Med 1995;333:1632-1633.
29. Norris JW, Hachinski VC: Intensive care management of stroke patients. Stroke 1976;7:573-577.
30. Norris JW, Hachinski VC: Stroke units or stroke centres? Stroke 1986;17:360-362.
31. Langhorne P, Williams BO, Gilchrist W, Howie K: Do stroke units save lives? Lancet 1993;342:395-398.
32. Strand T, Asplund K, Eriksson S, Hägg E, Lithner F, Wester PO: A non-intensive stroke unit reduces functional disability and the need for long-term hospitalization. Stroke 1985;16: 29-34.
33. Strand T, Asplund K, Eríksson S, Hägg E, Lithner F, Wester PO: Stroke unit care - Who benefits? Stroke 1986;17:377-381.
34. Bowen J, Yaste C: Effect of a stroke protocol on hospital costs of stroke patients. Neurology 1994;44:1961-1964.
35. Odderson IR, McKenna BS: A model for management of patients with stroke during the acute phase. Outcome and economic implications. Stroke 1993;24:1823-1827.
36. Kaste M, Palomaki H, Sarna S: Where and how should elderly stroke patients be treated? A randomized trial. Stroke 1995;26:249-253.
37. WHO Task Force on Stroke and Other Cerebrovascular Disorders: Recommendations on stroke prevention, diagnosis, and therapy. Report of the WHO Task Force on Stroke and Other Cerebrovascular Disorders. Stroke 1989;20:1407-1431.
38. Brott T, Fieschi C, Hacke W: General therapy of acute ischemic stroke; in Hacke W (ed): Neurocritical Care. Heidelberg, Springer, 1944, pp 553-577.
39. Norris JW, Hachinski VC: Misdiagnosis of stroke. Lancet 1982;i:328-331.
40. Britton M, Hindmarsh T, Murray V, Tyden SV: Diagnostic errors discovered by CT in patients with suspected stroke. Neurology 1984;34:1504-1507.
41. Hacke W, Zeumer H, Ferbert A, Brückmann H, del Zoppo GJ: Intra-arterial thrombolytic therapy improves outcome in patients with acute vertebrobasilar occlusive disease. Stroke 1988;19:1216-1222.
42. Hacke W, Schwab S, de Georgia M: Intensive care of acute ischaemic stroke. Cerebrovasc Dis 1994;4:385-392.
43. Kay R, Wong KS, Yu YL, Chan YW, Tsoi TH, Ahuja AT, Chan FL, Fong KY, Law CB, Wong A, Woo J: Low-molecular-weight heparin for the treatment of acute ischemic stroke. N Engl J Med 1995;333:1588-1593.
44. Britton M, de Faire U, Helmers C: Hazards of therapy for excessive hypertension in acute stroke. Acta Med Scand 1980;207:253-257.
45. Powers WJ: Acute hypertension after stroke. Neurology 1993;43:461-467.
46. Norris JW, Hachinski VC: High dose steroid treatment in cerebral infarction. Br Med J 1986;292:21-26.
47. Trust Study Group: Randomised, double-blind, placebo-controlled trial of nimodipine in acute stroke. Lancet 1990;336:1205-1209.
48. The American Nimodipine Study Group: Clinical trial of nimodipine in acute ischemic stroke. Stroke 1992;23:3-8.
49. Mohr JP, Orgogozo JM, Harrison MJG, Hennerici M, Wahlgren NG, Gelmers JH, Martinez-Vila E, Dycka J, Tettenborn D: Meta-analysis of oral nimodipine trials in acute ischaemic stroke. Cerebrovasc Dis 1994;4:177-210.
50. Sass I: Ganglioside GM1 in acute ischemic stroke. Stroke 1994;25:1141-1148.
51. Lenzi GL, Grigoletto F, Gent M, Roberts RS, Walker MD, Easton JD, Carolei A, Dorsey FC, Rocca WA, Bruno R, Patarnello F, Fieschi C: Early treatment of stroke with monosialogan-glioside GM-1. Efficacy and safety results of the early stroke trial. Stroke 1994;25:1552-1558.
52. Yu YL, Kumana CR, Lauder IJ, Cheung YK, Han FL, Kou M, Fong KY, Cheung RTF, Chang CM: Treatment of acute cortical infarct with intravenous glycerol. Stroke 1993;24:1119-1124.
53. Bayer AJ, Pathy MS, Newcombe R: Double-blind randomised trial of intravenous glycerol in acute stroke. Lancet 1987;i:405-407.
54. Asplund K: Randomized clinical trials of hemodilution in acute ischemic stroke. Acta Neurol Scand Suppl 1989;127:22-30.
55. Besson G, Bogousslavsky J: Current and future options for the prevention and treatment of stroke. CNS Drugs 1995;3:351-362.